Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity

Oncotarget

Volumn 6, Issue 37, 2015, Pages 39482-39492

  Özcan, Servet ^a   Alessio, Nicola ^b   Acar, Mustafa Burak ^a   Toprak, Güler ^a   Gönen, Zeynep Burcin ^a   Peluso, Gianfranco ^d   Galderisi, Umberto ^a,b,c  

^a ERCIYES UNIVERSITY   (Turkey)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c TEMPLE UNIVERSITY   (United States)

^d CNR   (Italy)

Author keywords

Apoptosis; Cancer; Gerotarget; Mesenchymal stem cells; Secretome; Senescence

Indexed keywords

DNA; ANTINEOPLASTIC AGENT; CONDITIONED MEDIUM;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARH 77 CELL LINE; ARTICLE; CANCER CELL LINE; CELL AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CELLULAR SECRETION; CONTROLLED STUDY; CULTURE MEDIUM; DNA DAMAGE; DNA REPLICATION; GENE ONTOLOGY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MESENCHYMAL STROMA CELL; MYELOMA CELL; OXIDATIVE STRESS; TANDEM MASS SPECTROMETRY; TUMOR GROWTH; AUTOPHAGY; CELL CULTURE; COCULTURE; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; MULTIPLE MYELOMA; PATHOLOGY; PHARMACOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DNA DAMAGE; HUMANS; MESENCHYMAL STROMAL CELLS; MULTIPLE MYELOMA; TANDEM MASS SPECTROMETRY;

EID: 84950135670     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5430     Document Type: Article

References (33)

1. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007; 8:729-740.
2. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446.
3. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. Senescenceassociated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS biology. 2008; 6:2853-2868.
4. Fumagalli M, d'Adda di Fagagna F. SASPense and DDRama in cancer and ageing. Nature cell biology. 2009; 11:921-923.
5. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nature reviews Cancer. 2009; 9:81-94.
6. Velarde MC, Demaria M, Campisi J. Senescent cells and their secretory phenotype as targets for cancer therapy. Interdisciplinary topics in gerontology. 2013; 38:17-27.
7. Coppe JP, Kauser K, Campisi J, Beausejour CM. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. The Journal of biological chemistry. 2006; 281:29568-29574.
8. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98:12072-12077.
9. Liu D, Hornsby PJ. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer research. 2007; 67:3117-3126.
10. Galderisi U, Giordano A. The gap between the physiological and therapeutic roles of mesenchymal stem cells. Medicinal research reviews. 2014; 34:1100-1126.
11. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. Journal of cellular physiology. 2007; 211:27-35.
12. Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell stem cell. 2012; 10:244-258.
13. Severino V, Alessio N, Farina A, Sandomenico A, Cipollaro M, Peluso G, Galderisi U, Chambery A. Insulin-like growth factor binding proteins 4 and 7 released by senescent cells promote premature senescence in mesenchymal stem cells. Cell death & disease. 2013; 4:e911.
14. Galderisi U, Giordano A, Paggi MG. The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents. World journal of stem cells. 2010; 2:5-12.
15. Bavik C, Coleman I, Dean JP, Knudsen B, Plymate S, Nelson PS. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer research. 2006; 66:794-802.
16. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annual review of pathology. 2010; 5:99-118.
17. Mastri M, Lin H, Lee T. Enhancing the efficacy of mesenchymal stem cell therapy. World journal of stem cells. 2014; 6:82-93.
18. Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PloS one. 2010; 5:e10088.
19. Yan H, Wu M, Yuan Y, Wang ZZ, Jiang H, Chen T. Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor. Biochemical and biophysical research communications. 2014; 448:212-217.
20. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013; 200:373-383.
21. Villarreal L, Mendez O, Salvans C, Gregori J, Baselga J, Villanueva J. Unconventional secretion is a major contributor of cancer cell line secretomes. Mol Cell Proteomics. 2013; 12:1046-1060.
22. Quijano C, Cao L, Fergusson MM, Romero H, Liu J, Gutkind S, Rovira II, Mohney RP, Karoly ED, Finkel T. Oncogene-induced senescence results in marked metabolic and bioenergetic alterations. Cell Cycle. 2012; 11:1383-1392.
23. Salama R, Sadaie M, Hoare M, Narita M. Cellular senescence and its effector programs. Genes Dev. 2014; 28:99-114.
24. Drewinko B, Mars W, Minowada J, Burk KH, Trujillo JM. ARH-77, an established human IgG-producing myeloma cell line. I. Morphology, B-cell phenotypic marker profile, and expression of Epstein-Barr virus. Cancer. 1984; 54:1883-1892.
25. Amaral JD, Xavier JM, Steer CJ, Rodrigues CM. The role of p53 in apoptosis. Discovery medicine. 2010; 9:145-152.
26. Liebermann DA, Hoffman B, Steinman RA. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene. 1995; 11:199-210.
27. Vjetrovic J, Shankaranarayanan P, Mendoza-Parra MA, Gronemeyer H. Senescence-secreted factors activate Myc and sensitize pretransformed cells to TRAIL-induced apoptosis. Aging cell. 2014; 13:487-496.
28. Nefedova Y, Landowski TH, Dalton WS. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Leukemia. 2003; 17:1175-1182.
29. Zanichelli F, Capasso S, Di Bernardo G, Cipollaro M, Pagnotta E, Carteni M, Casale F, Iori R, Giordano A, Galderisi U. Low concentrations of isothiocyanates protect mesenchymal stem cells from oxidative injuries, while high concentrations exacerbate DNA damage. Apoptosis: an international journal on programmed cell death. 2012; 17:964-974.
30. Alessio N, Bohn W, Rauchberger V, Rizzolio F, Cipollaro M, Rosemann M, Irmler M, Beckers J, Giordano A, Galderisi U. Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells. Cellular and molecular life sciences: CMLS. 2013; 70:1637-1651.
31. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nature protocols. 2006; 1:2856-2860.
32. Bonn F, Bartel J, Büttner K, Hecker M, Otto A, Becher D. Picking vanished proteins from the void: how to collect and ship/share extremely dilute proteins in a reproducible and highly efficient manner. Analytical Chemistry. 2014; 86:7421-7427.
33. Vizcaíno JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Ríos D, Dianes JA, Sun Z, Farrah T, Bandeira N, Binz PA, Xenarios I, Eisenacher M, Mayer G, Gatto L, Campos A, Chalkley RJ, Kraus HJ, Albar JP, Martinez-Bartolomé S, Apweiler R, Omenn GS, Martens L, Jones AR, Hermjakob H. ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination. Nature Biotechnology. 2014; 30:223-226.